Literature DB >> 850740

Angiography in giant cell tumors.

S Laurin.   

Abstract

Angiography in 9 cases of giant cell tumors of bone is described. All cases had a greatly increased vascularity of the lesion, with concomitant increase in the diameter of the supplying arteries and draining veins. The arterial branching on the surface as well as within the tumor seemed specific of giant cell tumors. Arteriovenous shunting was marked. There was a marked, long-lasting, non-homogeneous tumor stain. Examination with angiotensin enhanced the pathologic findings. The angiographic appearance, often simulating malignancy, combined with the appearance of the skeletal films, make the diagnosis of giant cell tumor almost certain. Difficulties will be expereinced in differentiating giant cell tumors from metastatic deposits, especially in the spine.

Entities:  

Mesh:

Year:  1977        PMID: 850740

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  5 in total

1.  Radiology of giant cell tumors of bone: computed tomography, arthro-tomography, and scintigraphy.

Authors:  T M Hudson; M Schiebler; D S Springfield; W F Enneking; I F Hawkins; S S Spanier
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

2.  Excisional biopsy for bone tumours.

Authors:  B M Persson; A Rydholm
Journal:  Arch Orthop Trauma Surg       Date:  1979-06-29

3.  Role of radiologic imaging in management planning of giant cell tumor of bone.

Authors:  E Levine; A A De Smet; J R Neff
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

4.  Late recurrence of giant-cell tumor of bone: pharmacoangiographic evaluation.

Authors:  S Laurin; L Ekelund; B Persson
Journal:  Skeletal Radiol       Date:  1980       Impact factor: 2.199

5.  Angiography in myeloma (plasmacytoma). A correlated angiographic and histologic study.

Authors:  S Laurin; M Akerman; L G Kindblom; B Gunterberg
Journal:  Skeletal Radiol       Date:  1979-04-10       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.